- 25B-NB3OMe
- N-(3-Methoxybenzyl)-4-bromo-2,5-dimethoxyphenethylamine
- 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(3-methoxyphenyl)methyl]ethan-1-amine
- 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)ethan-1-amine
Casale, JF; Hays, PA. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues—Part I Microgram J., 1 Jan 2012, 9 (2), 84–109. 4.6 MB. #5: 25B-NB3OMe GC,MS,IR
Hansen, M; Jacobsen, SE; Plunkett, S; Liebscher, GE; McCorvy, JD; Bräuner-Osborne, H; Kristensen, JL. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists Bioorg. Med. Chem., 15 Jun 2015, 23 (14), 3933-3937. 305 kB. https://doi.org/10.1016/j.bmc.2014.12.011 #1t
Hays, PA; Casale, JF. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) derivatives and differentiation from their 3-and 4-methoxybenzyl analogues - Part II Microgram J., 1 Jan 2014, 11 (1–4), 3–22. 8.1 MB. #5: 25B-NB3OMe NMR
Poulie, CBM; Pottie, E; Simon, IA; Harpsøe, K; D’Andrea, L; Komarov, IV; Gloriam, DE; Jensen, AA; Stove, CP; Kristensen, JL. Discovery of β-arrestin-biased 25CN-NBOH-derived 5-HT2A receptor agonists J. Med. Chem., 22 Sep 2022, 65 (18), 12031–12043. 9.5 MB. https://doi.org/10.1021/acs.jmedchem.2c00702 #4b LC,MS,NMR